ULUSAL TEDAVİ KILAVUZU 2011
8
Yararlanılan Kaynaklar
1. Protocols for the treatment of hemophilia and von Willebrand
disease. Third Edition 2008 (Treatment of Hemophilia
Monographs).
2. Wong T, Recht M. Current options and new developments in the
treatment of haemophilia. Drugs. 2011 Feb 12;71(3):305-20. doi:
10.2165/11585340-000000000-00000.x (Epub)
3. Guidelines for management of hemophilia. World Federation of
Hemophilia, 2005
4. Peake I, Selighsohn U, Gitel S, Kitchen S, Zielin A. The laboratory
diagnosis of haemophilia: Recommendations by the Laboratory
Activities Committee of the World Federation of Hemophilia.
Haemophilia 1995;1 (3):159-164
5. The diagnosis of Hemophilia. Canadian Hemophilia Society
2011.
6. Winikoff R, Lee C. Hemophilia carrier status and counseling the
symptomatic and asymptomatic adolescent. J Pediatr Adolesc
Gynecol. 2010;23(6 Suppl):S43-7
7. Manco-Johnson MJ. Advances in the care and treatment of
children with hemophilia. Adv Pediatr. 2010;57(1):287-94
8. Nair SC, Dargaud Y, Chitlur M, Srivastava A. Tests of global
haemostasis and their applications in bleeding disorders.
Haemophilia. 2010;16( Suppl 5):85-92
9. Goodeve AC, Rosén S, Verbruggen B. Haemophilia A and von
Willebrand’s disease. Haemophilia. 2010;16 (Suppl 5):79-84
10. McCraw A, Hillarp A, Echenagucia M. Considerations in the
laboratory assessment of haemostasis. Haemophilia. 2010;16
(Suppl 5):74-8
HEMOFİLİDE
KANAMA TEDAVİSİ
TANI VE TEDAVİ
KILAVUZU
U L U S A L T E D A V İ K I L A V U Z U 2 0 1 1
BÖLÜM
II.